Drugs / pINGmminiCD20
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00561756 | Oct 2007 → Nov 2015 | lymphoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pINGmminiCD20 | “the mouse extracellular domain of CD20, namely pINGmminiCD20” NCT00561756 ↗ |
| Modality | Vaccine | “xenogeneic CD20 DNA vaccination” NCT00561756 ↗ |
| Route | Intramuscular | “intramuscular DNA vaccination” NCT00561756 ↗ |